Stock Financial Ratios and Split History

ICAD / icad, inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)72.09
Enterprise Value ($M)62.74
Book Value ($M)25.04
Book Value / Share1.55
Price / Book3.17
NCAV ($M)6.32
NCAV / Share1.62
Price / NCAV12.20
Income Statement (mra) ($M)
Net Income-10.10
Balance Sheet (mrq) ($M)
Cash & Equivalents11.26
Cash / Share0.70
Quick Ratio1.26
Current Ratio1.55
Share Statistics
Common Stock Shares Outstanding16,074,832
Common Shares Outstanding16,157,466
Weighted Average Number Of Diluted Shares Outstanding15,932,000
Weighted Average Number Of Shares Outstanding Basic15,932,000
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.40
Return on Assets (ROA)-0.26
Return on Equity (ROE)-0.40
Identifiers and Descriptors
Central Index Key (CIK)749660
Industry Groups
SIC 3841 - Surgical and Medical Instruments and Apparatus
Related CUSIPS
44934S906 44934S956

Split History

Stock splits are used by icad, inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Peers - Surgical and Medical Instruments and Apparatus (3841)

Related News Stories

iCAD's (ICAD) CEO Ken Ferry on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Good day, and welcome to the iCAD Medical Third Quarter 2017 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the conference over to Bob Yedid, with LifeSci Advisors. Please go ahead. (20-0)

CUSIP: 44934S206